146 related articles for article (PubMed ID: 10085538)
1. Rescue of K562 cells from MDM2-modulated p53-dependent apoptosis by growth factor-induced differentiation.
Mahdi T; Alcalay D; Cognard C; Tanzer J; Kitzis A
Biol Cell; 1998 Dec; 90(9):615-27. PubMed ID: 10085538
[TBL] [Abstract][Full Text] [Related]
2. Effects of the antisense myb expression on hemin- and erythropoietin-induced erythroid differentiation of K562 cells.
Kamano H; Tanaka T; Ohnishi H; Kubota Y; Ikeda K; Takahara J; Irino S; Ottalenghi S
Biochem Mol Biol Int; 1994 Aug; 34(1):85-92. PubMed ID: 7849628
[TBL] [Abstract][Full Text] [Related]
3. p53 causes butein‑mediated apoptosis of chronic myeloid leukemia cells.
Woo SM; Choi YK; Kim AJ; Cho SG; Ko SG
Mol Med Rep; 2016 Feb; 13(2):1091-6. PubMed ID: 26676515
[TBL] [Abstract][Full Text] [Related]
4. Involvement of the tumor suppressor gene p53 in tumor necrosis factor-induced differentiation of the leukemic cell line K562.
Ehinger M; Nilsson E; Persson AM; Olsson I; Gullberg U
Cell Growth Differ; 1995 Jan; 6(1):9-17. PubMed ID: 7718488
[TBL] [Abstract][Full Text] [Related]
5. Facilitation of adenoviral wild-type p53-induced apoptotic cell death by overexpression of p33(ING1) in T.Tn human esophageal carcinoma cells.
Shimada H; Liu TL; Ochiai T; Shimizu T; Haupt Y; Hamada H; Abe T; Oka M; Takiguchi M; Hiwasa T
Oncogene; 2002 Feb; 21(8):1208-16. PubMed ID: 11850840
[TBL] [Abstract][Full Text] [Related]
6. Identification of a tumor-derived p53 mutant with novel transactivating selectivity.
Pan Y; Haines DS
Oncogene; 2000 Jun; 19(27):3095-100. PubMed ID: 10871862
[TBL] [Abstract][Full Text] [Related]
7. MDM2 protein confers the resistance of a human glioblastoma cell line to cisplatin-induced apoptosis.
Kondo S; Barnett GH; Hara H; Morimura T; Takeuchi J
Oncogene; 1995 May; 10(10):2001-6. PubMed ID: 7761100
[TBL] [Abstract][Full Text] [Related]
8. Human lymphoblastoid cell lines expressing mutant p53 exhibit decreased sensitivity to cisplatin-induced cytotoxicity.
Piovesan B; Pennell N; Berinstein NL
Oncogene; 1998 Nov; 17(18):2339-50. PubMed ID: 9811465
[TBL] [Abstract][Full Text] [Related]
9. Small-molecule MDM2 inhibitor LQFM030-induced apoptosis in p53-null K562 chronic myeloid leukemia cells.
de Oliveira Ribeiro H; Cortez AP; de Ávila RI; da Silva ACG; de Carvalho FS; Menegatti R; Lião LM; Valadares MC
Fundam Clin Pharmacol; 2020 Aug; 34(4):444-457. PubMed ID: 32011031
[TBL] [Abstract][Full Text] [Related]
10. BCR/ABL activates mdm2 mRNA translation via the La antigen.
Trotta R; Vignudelli T; Candini O; Intine RV; Pecorari L; Guerzoni C; Santilli G; Byrom MW; Goldoni S; Ford LP; Caligiuri MA; Maraia RJ; Perrotti D; Calabretta B
Cancer Cell; 2003 Feb; 3(2):145-60. PubMed ID: 12620409
[TBL] [Abstract][Full Text] [Related]
11. p53 stabilization induces apoptosis in chronic myeloid leukemia blast crisis cells.
Peterson LF; Mitrikeska E; Giannola D; Lui Y; Sun H; Bixby D; Malek SN; Donato NJ; Wang S; Talpaz M
Leukemia; 2011 May; 25(5):761-9. PubMed ID: 21350558
[TBL] [Abstract][Full Text] [Related]
12. The loss of mdm2 induces p53-mediated apoptosis.
de Rozieres S; Maya R; Oren M; Lozano G
Oncogene; 2000 Mar; 19(13):1691-7. PubMed ID: 10763826
[TBL] [Abstract][Full Text] [Related]
13. [New insight into the mechanism of p53 inducing leukemia cell apoptosis].
Chen YZ; Wu Y; Liang M; Li NN; Zhang ZX; Lu LH
Zhonghua Xue Ye Xue Za Zhi; 2003 Dec; 24(12):640-3. PubMed ID: 14761612
[TBL] [Abstract][Full Text] [Related]
14. c-Myc antagonizes the effect of p53 on apoptosis and p21WAF1 transactivation in K562 leukemia cells.
Ceballos E; Delgado MD; Gutierrez P; Richard C; Müller D; Eilers M; Ehinger M; Gullberg U; León J
Oncogene; 2000 Apr; 19(18):2194-204. PubMed ID: 10822369
[TBL] [Abstract][Full Text] [Related]
15. Altered expression of p53 and MDM2 proteins in hematological malignancies.
Koníková E; Kusenda J
Neoplasma; 2003; 50(1):31-40. PubMed ID: 12687276
[TBL] [Abstract][Full Text] [Related]
16. Mcl-1, an early-induction molecule, modulates activin A-induced apoptosis and differentiation of CML cells.
Fukuchi Y; Kizaki M; Yamato K; Kawamura C; Umezawa A; Hata Ji ; Nishihara T; Ikeda Y
Oncogene; 2001 Feb; 20(6):704-13. PubMed ID: 11314004
[TBL] [Abstract][Full Text] [Related]
17. [The effect of the tumor suppressor p53 and its mutant forms on the differentiation and viability of K562 leukemic cells].
Kremenetskaia OS; Logacheva NP; Baryshnikov AIu; Chumakov PM; Kopnin BP
Tsitologiia; 1996; 38(12):1280-93. PubMed ID: 9163103
[TBL] [Abstract][Full Text] [Related]
18. A truncated isoform of the PP2A B56gamma regulatory subunit reduces irradiation-induced Mdm2 phosphorylation and could contribute to metastatic melanoma cell radioresistance.
Koma YI; Ito A; Watabe K; Kimura SH; Kitamura Y
Histol Histopathol; 2004 Apr; 19(2):391-400. PubMed ID: 15024700
[TBL] [Abstract][Full Text] [Related]
19. p53 protein stability in tumour cells is not determined by mutation but is dependent on Mdm2 binding.
Midgley CA; Lane DP
Oncogene; 1997 Sep; 15(10):1179-89. PubMed ID: 9294611
[TBL] [Abstract][Full Text] [Related]
20. Selective compartmentalization of different mdm2 proteins within the nucleus.
Maxwell SA
Anticancer Res; 1994; 14(6B):2541-7. PubMed ID: 7872679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
